Coagulation factors in the airways in moderate and severe asthma

F. Brims, A. Chauhan, B. Higgins, J. Shute (Portsmouth, United Kingdom)

Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury
Session: Mechanisms of lung injury: COPD, asthma and acute lung injury
Session type: Thematic Poster Session
Number: 3623
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Brims, A. Chauhan, B. Higgins, J. Shute (Portsmouth, United Kingdom). Coagulation factors in the airways in moderate and severe asthma. Eur Respir J 2009; 34: Suppl. 53, 3623

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Severe bronchial asthma: risk factors
Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond
Year: 2008


Factors driving airway eosinophilia in prednisone-dependent severe asthma
Source: International Congress 2017 – Pathophysiology and emerging therapies for severe asthma
Year: 2017


Risk factors for severe exacerbations in asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 199s
Year: 2002

Parameters associated with persistent airflow obstruction in chronic severe asthma
Source: Eur Respir J 2004; 24: 122-128
Year: 2004



Role of neutrophils in airway inflammation in children with severe persistent asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 142s
Year: 2002

Distribution of biomarkers in severe asthma and severe uncontrolled asthma
Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research
Year: 2021



Risk factors for moderate exacerbations in childhood asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 163s
Year: 2004

Allergic rhinitis co-morbidity as risk factor on lung function parameters recovery after asthma exacerbation
Source: International Congress 2019 – Epidemiology of childhood respiratory diseases
Year: 2019

Risk factors for severe asthma among adults with asthma
Source: Virtual Congress 2020 – Diagnosis and management of asthma
Year: 2020




The relationship between airways inflammation, atopy and bronchial hyper-responsiveness in young adults with mild to moderate asthma
Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Year: 2010

Predictors of exercise-induced airways obstruction in patients with mild asthma.
Source: Virtual Congress 2020 – Exploring exercise responses in respiratory diseases
Year: 2020


Prognostic factors in severe eosinophilic asthma
Source: International Congress 2018 – Biomarkers and lung function in airway disease
Year: 2018




Prognostic factors in severe eosinophilic asthma in children
Source: International Congress 2018 – The bad and the ugly in paediatric asthma: comorbidities and exacerbations
Year: 2018

Risk factors for severe bronchial asthma in young adults with childhood-onset asthma
Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control
Year: 2007


Neutrophilic inflammation in severe asthmatics and COPD patients with the same severity of airway obstruction
Source: Eur Respir J 2002; 20: Suppl. 38, 505s
Year: 2002

Special problems of severe asthma in childhood
Source: Eur Respir Mon 2011; 51: 59-81
Year: 2011


High BMI in severe asthma is associated with co-morbid factors but not with increased airway inflammation or -obstruction
Source: Eur Respir J 2002; 20: Suppl. 38, 406s
Year: 2002

Effects of formoterol-budesonide combination on residual eosinophilic inflammation in distal airway of patients with well-controlled moderate asthma
Source: Annual Congress 2011 - Asthma management and response
Year: 2011

Risk factors of bronchial asthma in allergic rhinitis patients
Source: Eur Respir J 2003; 22: Suppl. 45, 372s
Year: 2003

Benralizumab for severe asthma associated with extra-airway eosinophilic diseases
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020